Updated Covid Vaccines now available. Please click on COVID-19 Services tab for more information.
Little Silver Family Pharmacy Logo

Get Healthy!

Results for search "Cancer: Prostate".

Health News Results - 84

Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new study reports.

Procedures like radiation therapy and prostate surgery are being employed more often in these men, causing side effects like incontinence and impotence without adding any mo...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new study finds.

Surgery for prostate cancers increases a man’s risk of urinary or sexual complications more than sevenfold, researchers reported Nov. 7 in the journal

Exposure to any one of 22 pesticides may bring heightened odds of developing prostate cancer, a new analysis suggests.

The study was conducted over decades because prostate cancer is known to grow very slowly, noted a team led by Dr. Simon John Christoph Soerensen, of Stanford University in California.

The researchers looke...

Artificial intelligence might be able to help doctors detect the prostate cancers most likely to be life-threatening to men, a new study suggests.

An AI program successfully identified and outlined 85% of the most aggressive prostate tumors seen on MRI scans of more than 700 patie...

A healthy diet can help keep prostate cancer in check, a new study finds.

The better a man eats, the less likely his low-grade prostate cancer will progress to a more dangerous state, researchers reported Oct. 17 in the journal

  • Dennis Thompson HealthDay Reporter
  • |
  • October 21, 2024
  • |
  • Full Page
  • Having close family and friends who care about their health makes women more likely to get regularly screened for cancer, a new study has found.

    Women are more likely to undergo regular cancer screening if they have a tighter web of social and emotional connections, researchers reported Oct. 17 in the journal Cancer Causes & Contro...

    A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer.

    A phase 3 clinical trial has shown that circulating tumor cell (CTC) counts can predict which men are likely to respond to standard treatment and live longest and which might benefit from more aggressive new drug trials.

    CTCs are rare cancer cells that tumors shed in the blood. The...

    A new survey finds the majority of American men believe the first step in prostate cancer screening is an invasive rectal exam by their doctor.

    That's not true, but mistaken beliefs like these could keep men from getting screened until prostate cancer is discovered far too late, the American Cancer S...

    Men, take note: Cancer cases and deaths among males will jump globally by 84% and 93%, respectively, by 2050, new research predicts.

    Published Monday in the journal Cancer, the study found the increases were greater among men 65 and older and in countries and territories with a low or medium "human d...

    For years, the treatment of early-stage prostate cancers that haven't spread beyond the organ have often included the removal of nearby lymph nodes in the pelvis. It's done as a precaution and as a means of "staging" the disease.

    Now, a major expert review on the topic suggests that, in many cases, men in this situation may be better off keeping their lymph nodes.

    Doing so may help...

    Cancer rates are rising among Gen Xers and millennials, a new study reports.

    Successively younger generations are more frequently being diagnosed half of the 34 known cancer types, researchers found.

    For example, people born in 1990 have two to three times higher...

    The stress of living in a poor neighborhood might contribute to higher rates of aggressive prostate cancer in Black men, a new study warns.

    Black men are more than twice as likely to die from prostate cancer than white men, and more likely to develop it as well, the researchers no...

    American men are blowing their best chance to head off cancer or spot it early, when it's easiest to treat, a new survey warns.

    More than 6 in 10 (65%) men in the nationwide survey said they are behind on at least one routine cancer screening, while nearly 1 in 5 admitted they don't even schedule their own health care appointments. 

    Those are the key findings from the annual

    Current screening standards could miss early-stage prostate cancer in transgender women, a new study warns.

    Prostate cancer tests look for prostate-specific antigen (PSA), a protein produced by the small gland. Blood levels of PSA tend to be elevated in people with prostate cancer.

    But the estrogen that many transgender women take as part of their gender-affirming care "drastically ...

    Prostate medications might help reduce the risk of a specific type of dementia, a new study suggests.

    People were less likely to develop Lewy body dementia when taking drugs designed to treat urinary symptoms caused by an enlarged prostate, researchers reported June 19 in the journal Neurology.

    ...

    British retiree David Butler was surprised to find that he had prostate cancer, and that it had spread to the lymph nodes and other places near the prostate.

    "I had literally no symptoms apart from needing to pee more quickly whenever I did go to the toilet,"Butler, 77, said in a ...

    For a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors advise a "watch-and-wait" approach instead of active treatment.

    Now, a study of almost 2,200 patients followed for up to a decade finds that, for most, that decision may be a wise one.

    "In this study, 10 years after diagnosis, 49% of men remained free of progression or treatment, less t...

    Following a vegetarian or vegan diet might just buy you a longer, healthier life, a new review finds.

    Staying away from meat was tied to a reduced risk of heart disease, cancer and early death, researchers reported in a study published Wednesday in the journal PLOS One.

    After combing through nearly 50 studies on ...

    When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only?

    Right now, an invasive biopsy is the only way to answer that query, but researchers say they've developed a urine test that could do the job instead.

    The test, called MyProstateScore2.0 (MPS2), was developed by researchers at th...

    In a letter sent to teaching hospitals and medical schools across the country, the U.S. Department of Health and Human Services said Monday that written consent must be obtained from patients before performing sensitive procedures such as pelvis and prostate exams.

    The agency noted that it "is aware of media reports, as well as medical and scientific literature, highlighting instances whe...

    Men with prostate cancer treated at hospitals participating in a special drug-pricing program were more likely to stick to their therapy than patients elsewhere, new research reveals.

    The federal 340B Drug Program requires the pharmaceutical industry to discount drugs sold to participating hospitals t...

    A new British study suggests that the prostate-specific antigen (PSA) test, long used to spot prostate cancers, might lead to overdiagnosis in Black men.

    Researchers now theorize that Black men may have naturally higher levels of the antigen in their blood than white men, but that it does not indicate any higher risk for prostate cancer.

    If Black patients are being overdiagnosed, th...

    The red meat diet associated with masculinity could be the worst thing for men dealing with prostate cancer, a new study says.

    Prostate cancer patients who limit meat and dairy but eat lots of plant-based foods tend to suffer less erectile dysfunction, urinary incontinence and other embarrassing side effects associated with their treatment, researchers say.

    Men who ate the most plan...

    MONDAY, Feb. 12, 2024 (Healthday News) -- Defense Secretary Lloyd Austin III, who spent time in intensive care last month for complications related to prostate cancer surgery performed in December, has returned to the hospital with bladder issues, the Pentagon announced Sunday.

    "Tonight, after a series of tests and evaluations, the Secretary was admitted into the critical care unit at Wal...

    Even small increases in a man's cardio fitness can significantly reduce his risk of developing prostate cancer, researchers report.

    An annual increase in aerobic fitness of 3% or more is linked to a 35% lower risk of prostate cancer, according to a report published Jan. 30 in the British Journal of Sports Medicine.

    "Improvements in [cardiorespiratory fitness] in adult men s...

    Britain's King Charles III returned home on Monday after a planned prostate surgery, the same day his daughter-in-law Kate Middleton, the Princess of Wales, was also discharged following an undisclosed abdominal surgery.

    Both had been treated at the London Clinic private hospital.

    The King spent three nights there after surgery on Friday for an enlarged prostate, according to from B...

    Defense Secretary Lloyd Austin will not need any more treatment for his prostate cancer and his prognosis is "excellent," his doctors say.

    The news came after a follow-up appointment Austin had at Walter Reed National Military Center on Friday.

    "Beyond planned physical therapy and regular post-prostatectomy follow-up appointments, he has no planned further treatment for his cancer,"...

    Combining two or three testosterone-blocking drugs prevents the spread of prostate cancer better than just a single medication, a new clinical trial has found.

    Men who received two or three hormone blockers remained cancer-free with lower PSA levels for longer than those only receiving one drug, researchers found.

    Once off the treatment, men who took the combo therapy saw testostero...

    A new study may provide help to men newly diagnosed with prostate cancer who are faced with a daunting array of treatment options.

    The study tracked 10-year outcomes and treatment side effects for nearly 2,500 men first diagnosed with prostate cancer in 2011 and 2012.

    "Unlike previous studies, it focuses on contemporary treatment options,"explained study lead author

  • Ernie Mundell HealthDay Reporter
  • |
  • January 24, 2024
  • |
  • Full Page
  • Cancer deaths continue to decline in the United States, with more than 4 million deaths prevented since 1991, a new report shows.

    But more people are developing cancers than ever, making the dreaded disease a continued threat to human health, according to the new report

  • Dennis Thompson HealthDay Reporter
  • |
  • January 17, 2024
  • |
  • Full Page
  • Following two weeks of hospital care for complications from prostate cancer surgery, U.S. Defense Secretary Lloyd Austin has been released from Walter Reed National Military Medical Center, the Pentagon announced Monday.

    "Secretary Austin progressed well throughout his stay and his streng...

    U.S. Secretary of Defense Lloyd Austin remains hospitalized while recovering from complications related to a December surgery to treat prostate cancer, the Pentagon announced Tuesday.

    His doctors at Walter Reed National Military Medical Center,

    Black men diagnosed with advanced prostate cancer are significantly less likely to be prescribed hormone therapy that could extend their lives, compared to other racial and ethnic groups, a new study shows.

    Studies have shown that hormone therapy can effectively control the growth of prostate tumors by inhibiting the action of male hormones like testosterone or reducing their levels in th...

    Even with the same prostate-specific antigen (PSA) levels, Black men are more likely to have prostate cancer than white men, new research shows.

    The findings point to the need for earlier and more frequent screening, the researchers noted.

    It's already known that Black men in the United States are more likely to develop prostate cancer than their white peers. After diagnosis, they'r...

    Men of all races and ethnic groups who have prostate cancer fare equally well when access to care is identical, a new study finds.

    The disparity in outcomes from prostate cancer between Black, Hispanic and white men disappears when treatment and care are the same, as it is in U.S. Veterans Health Administration (VA) hospitals. In fact, Black and Hispanic men, on average fared better than...

    It's important for men to be familiar with the warning signs of prostate cancer and get screened because it's the second-leading cause of cancer death in men, an expert says.

    While there will be more than 288,000 diagnoses and nearly 35,000 deaths this year, there are also 3.5 million American men who have the disease and are still alive.

    Black men have the highest death rate for ...

    While new research suggests cancer screenings are not extending lives for the most part, the study's authors stressed that there are still good reasons why people should continue with screenings.

    Their review of clinical trials looked at six kinds of common cancer tests -- mammography, colonoscopy, fecal occult blood testing (FOBT) or endoscopy, prostate-specific antigen (PSA) tests and c...

    A technique that uses imaging technology as a guide can make radiation therapy safer for patients undergoing treatment for prostate cancer, a new research review finds.

    The technology enables clinicians to accurately aim the radiation beams at the prostate, while avoiding bladder, urethra and rectal tissue. This, in turn, reduces short-term side effects for patients, according to research...

    The need to increase racial diversity among U.S. health care providers is important for many reasons. Among them, Black patients are more likely to believe Black physicians or patients than sources who are white, new research finds.

    The race of the presenter in videos about prostate cancer did not appear to make a difference to white patients, the study noted. But Black Americans were 1.6...

    A preclinical study offers a potential new therapy for treatment-resistant prostate cancer, offering new hope for men with the disease.

    The study used the chemotherapy drug cisplatin, administered orally, to disrupt the metabolism of prostate cancer cells and bring the medication directly into treatment-resistant cells.

    University of Miami researchers validated their targets in huma...

    A man's cardio fitness might influence whether he'll develop -- or survive -- three of the most common cancers in males, a new Swedish study reports.

    Higher levels of cardio fitness are associated with a significantly lower risk of developing colon and lung cancers, researchers report.

    Cardio fitness also plays a role in a man's likelihood of surviving prostate, colon and lung cance...

    No man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it is treated.

    Prostate cancer affects one in seven men. According to the American Cancer Society (ACS)...

    The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men.

    But researchers think they've found a way to make the blood test for prostate-specific antigen (PSA) accurate enough to significantly reduce overdiagnosis and better predict dangerous cance...

    You're due for a prostate exam, but you don't know what to expect.

    So, what is this exam like?

    Regular check-ups are essential for maintaining your health, and a prostate exam is crucial to preventive care for men. Not only is it a screening test for early signs of prostate cancer, but it also helps detect other potential health issues.

    Here, experts walk you ...

    Black men die from prostate cancer more frequently than other men. They also shoulder the greatest burden of advanced prostate disease around the world.

    Now, new research shows genetics are not to blame.

    Rather, the culprit is treatment disparities, researchers report.

    "I believe this is the largest and most representative genomic study of advanced prostate cancer in men of A...

    When young men pack on excess weight during their teens and 20s, they may inadvertently drive up their risk for prostate cancer later on.

    The concern stems from new research that examined several decades' worth of weight fluctuations and prostate cancer rates among nearly 260,000 men in Sweden.

    The men ranged in age from 17 to 60. Researchers initially observed that overall, partici...

    Transgender women have a risk of prostate cancer, even after gender-affirming surgeries, yet aren't "on the radar"for screening by clinicians, new research finds.

    "The entire medical literature on prostate cancer in transgender women, prior to this study, consisted of 10 case reports, leading some to believe it was rare. But this paper shows it isn't as rare as those case reports suggest,...

    Over the last decade, more and more Americans with early-stage prostate cancer have put off radiation and surgery, the standard treatment options, new research indicates.

    Instead, many U.S. men with low- or intermediate-risk prostate cancer have embraced "active surveillance,"in which their disease is carefully monitored for any sign of progression that might eventually require inter...

    An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment.

    The drug's maker, Novartis Pharmaceuticals Corp., has said it can't keep up with demand for the medication, known as Pluvicto.

    Doctors have had to reschedule some patients who were due to start their first doses of the treatment. Mean...

    A man with prostate cancer who takes the "watch-and-wait"approach has the same long-term survival odds as those who undergo radiation therapy or surgery, according to a new large-scale study.

    Patients had the same 97% survival rate after a decade and a half whether doctors treated their tumor or simply put it under observation, British researchers found.

    "Survival from prostate canc...